Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 3, 2012, Pages 334-343

  Qin, Shucun ^a,b,c   Kamanna, Vaijinath S ^a,b   Lai, Jack H ^d   Liu, Tianjiao ^a,b   Ganji, Shobha H ^a,b   Zhang, Linhua ^a,b   Bachovchin, William W ^d   Kashyap, Moti L ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAISHAN MEDICAL UNIVERSITY   (China)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ApoAI mimetics; apolipoprotein AI; atherosclerosis; high density lipoproteins; inflammation

Indexed keywords

APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; L4F PEPTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE DERIVATIVE; REV D4F PEPTIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA ROOT; AORTA SINUS; ARTICLE; BODY WEIGHT; CHEMOTAXIS; CHOLESTEROL BLOOD LEVEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; SOLID PHASE SYNTHESIS; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; CHEMOKINE CCL2; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; HUMANS; LIPIDS; MACROPHAGES; MICE; MICE, KNOCKOUT; PEPTIDES;

EID: 84865125809     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248411434598     Document Type: Article

References (21)

1. Meyers CD, Kashyap ML. Pharmacologic elevation of high-density lipoproteins: recentinsights on mechanism of action and atherosclerosis protection. Curr Opin Cardiol. 2004 ; 19 (4). 366-373 (Pubitemid 38916496)
2. Navab M, Imes SS, Hama SY, et al. Monocyte transmigration induced by modification o low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991 ; 88 (6). 2039-2046
3. Tangirala RK, Tsukamoto K, Chun SH, et al. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999 ; 100 (17). 1816-1822 (Pubitemid 29498389)
4. Forrester JS, Shah PK. Emerging strategies for increasing high-density lipoprotein. Am J Cardiol. 2006 ; 98 (11). 1542-1549 (Pubitemid 44779488)
5. Anantharamaiah GM, Navab M, Reddy ST, et al. Synthetic peptides: managing lipid disorders. Curr Opin Lipidol. 2006 ; 17 (3). 233-237 (Pubitemid 43786056)
6. Anantharamaiah GM, Jones JL, Brouillette CG, et al. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem. 1985 ; 260 (18). 10248-10255 (Pubitemid 16246560)
7. Datta G, Chaddha M, Hama S, et al. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res. 2001 ; 42 (7). 1096-1104 (Pubitemid 32645791)
8. Garber DW, Datta G, Chaddha M, et al. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res. 2001 ; 42 (4). 545-552 (Pubitemid 32366997)
9. Navab M, Anantharamaiah GM, Hama S, et al. Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002 ; 105 (3). 290-292 (Pubitemid 34106174)
10. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995 ; 36 (11). 2320-2328
11. Shih DM, Gu L, Hama S, et al. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest. 1996 ; 97 (7). 1630-1639 (Pubitemid 26105474)
12. Navab M, Susan Y, Hama C, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000 ; 41(9): 1481-1494
13. Bielicki JK, Oda MN. Apolipoprotein A-IMilano and apolipoprotein A-IParis exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry. 2002 ; 41 (6). 2089-2096 (Pubitemid 34132283)
14. Murase T, Kume N, Hase T, et al. Gallates iInhibit cytokine-induced nuclear translocation of NF-B and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1999 ; 19 (6). 1412-1420 (Pubitemid 29263010)
15. Jiang MZ, Tsukahara H, Ohshima Y, et al. Effects of antioxidants and nitric oxide on TNF-?-induced adhesion molecule expression and NF-?B activation in human dermal microvascular endothelial cells. Life Sci. 2004 ; 75 (10). 1159-1170 (Pubitemid 38829341)
16. Chen XL, Grey JY, Thomas S, et al. Sphingosine kinase-1 mediates TNF-?-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. Am J Physiol Heart Circ Physiol. 2004 ; 287 (4). H1452 - H1458
17. Navab M, Anantharamaiah GM, Reddy ST, et al. Oral D-4F causes formation of pre-b high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004 ; 109 (25). 3215-3220
18. Navab M, Hama SY, Anantharamaiah GM, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000 ; 41 (9). 1495-1508
19. Navab M, Berliner JA, Subbanagounder G, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioslcer Thromb Vasc Biol. 2001 ; 21 (4). 481-488 (Pubitemid 32323377)
20. Garber DW, Datta G, Chadda M, et al. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res. 2001 ; 42 (4). 545-552 (Pubitemid 32366997)
21. Bloedon LT, Dunbar R, Duffy D, et al. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J Lipid Res. 2008 ; 49 (6). 1344-1352